Patent · US Active

Marker sequences for diagnosing and stratifying systemic sclerosis patients

US11609237B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Oncimmune Germany GmbH · DE

Inventors

Petra BUDDE · Dortmund, DE
Peter Schulz-Knappe · Hemmingen, DE
Angelika Lüking · Bochum, DE
Martin GAMER · Dortmund, DE

Key dates

Filing date	Dec 4, 2019
Grant date	Mar 21, 2023
Priority date	—
Expiry date	Mar 10, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; SSc) and to the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.